Article

World Glaucoma Day set for March 6; OT official publication

Sydney, Australia-The first World Glaucoma Day will be March 6.

Sydney, Australia-The first World Glaucoma Day will be March 6. The World Glaucoma Association (WGA) and the World Glaucoma Patient Organization (WGPA) are sponsoring the observance.

Ophthalmology Times has been named the official publication of the event and will provide coverage of the awareness and educational activities organized by glaucoma institutions and local patient support groups worldwide. The schedule is listed at www.wgday.net.

“Because glaucoma strikes so silently and gradually, it is absolutely crucial to educate people about the value of early detection,” said Robert Ritch, MD, professor and chief of glaucoma services at the New York Eye and Ear Infirmary, co-founder of the WGPA, and a member of the World Glaucoma Day committee for the WGA. “For a disease that causes permanent blindness, it is truly unacceptable that so many people remain unaware of its impact and consequences. Individuals in our country need to be much more vigilant about glaucoma, especially if they fall into one of the higher-risk groups.”

The WGA is an independent professional global organization composed of medical experts and institutions throughout the world. The WGPA is an umbrella organization that supports glaucoma associations and networks worldwide.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.